Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

DisTal Arterio-Venous Fistula Feasibility

NCT: NCT07786025 · ACTIVE_NOT_RECRUITING

NCT IDNCT07786025
StatusACTIVE_NOT_RECRUITING
Start Date2024-12-02
Completion2027-03-01
SponsorDistal Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

The goal of this clinical trial is to evaluate, in a clinical setting, the feasibility of vein enlargement at the site of the arteriovenous fistula created percutaneously, using the DisTal device ("DisTal AVF"). The main question the study aims to answer is what is the rate of successful enlargement of the vein at the site of DisTal AVF within 100 days of the procedure, as confirmed by ultrasound.

Frequently Asked Questions

What is DisTal Arterio-Venous Fistula Feasibility?

DisTal Arterio-Venous Fistula Feasibility is a clinical trial registered under NCT07786025. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT07786025?

The current status of NCT07786025 (DisTal Arterio-Venous Fistula Feasibility) is: ACTIVE_NOT_RECRUITING.

When did DisTal Arterio-Venous Fistula Feasibility start?

DisTal Arterio-Venous Fistula Feasibility started on 2024-12-02.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑